Search

Author/Creator Sundy, John S

1. 086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs. (12th April 2019)

Authors:
Walker, David; Genovese, Mark C; Kalunian, Kenneth; Gottenberg, Jacques-Eric; de Vlam, Kurt; Mozaffarian, Neelufar; Bartok, Beatrix; Matzkies, Franziska; Gao, Jie; Guo, Ying; Tasset, Chantal; Sundy, John S; Takeuchi, Tsutomu
Journal:
Rheumatology
Issue:
Volume 58(2019)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Issue 10 (9th September 2015)

Authors:
Neogi, Tuhina; Jansen, Tim L Th A; Dalbeth, Nicola; Fransen, Jaap; Schumacher, H Ralph; Berendsen, Dianne; Brown, Melanie; Choi, Hyon; Edwards, N Lawrence; Janssens, Hein J E M; Lioté, Frédéric; Naden, Raymond P; Nuki, George; Ogdie, Alexis; Perez-Ruiz, Fernando; Saag, Kenneth; Singh, Jasvinder A...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 10(2015)
Page Start:
1789
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. Issue 6 (15th January 2021)

Authors:
Westhovens, René; Rigby, William F C; van der Heijde, Désirée; Ching, Daniel W T; Stohl, William; Kay, Jonathan; Chopra, Arvind; Bartok, Beatrix; Matzkies, Franziska; Yin, Zhaoyu; Guo, Ying; Tasset, Chantal; Sundy, John S; Jahreis, Angelika; Mozaffarian, Neelufar; Messina, Osvaldo Daniel; Landewé...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 6(2021)
Page Start:
727
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. Issue 7 (27th January 2021)

Authors:
Combe, Bernard; Kivitz, Alan; Tanaka, Yoshiya; van der Heijde, Désirée; Simon, J Abraham; Baraf, Herbert S B; Kumar, Uma; Matzkies, Franziska; Bartok, Beatrix; Ye, Lei; Guo, Ying; Tasset, Chantal; Sundy, John S; Jahreis, Angelika; Genovese, Mark C; Mozaffarian, Neelufar; Landewé, Robert B M; Bae,...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 7(2021)
Page Start:
848
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. O09 Pooled safety analyses from Phase 3 studies of filgotinib in patients with RA. (20th April 2020)

Authors:
Walker, David; Winthrop, Kevin; Genovese, Mark C; Combe, Bernard G; Tanaka, Yoshiya; Kivitiz, Alan; Matzkies, Franziska; Bartok, Beatrix; Ye, Lie; Guo, Ying; Tasset, Chantal; Sundy, John S; Keystone, Edward; Westhovens, Rene; Rigby, William; Burmester, Gerd R
Journal:
Rheumatology
Issue:
Volume 59(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P133 Filgotinib in patients with RA with inadequate response to methotrexate: FINCH 1 52-week efficacy and patient reported outcomes data. (26th April 2021)

Authors:
Walker, David; Kivitz, Alan; Tanaka, Yoshiya; Lee, Susan; Ye, Lei; Hu, Hao; Matzkies, Franziska; Bartok, Beatrix; Bartok, Beatrix; Guo, Ying; Sundy, John S; Jahreis, Angelika; Besuyen, Robin; Combe, Bernard; van der Heijde, Désirée; Simon-Campos, J-Abraham; Baraf, Herbert S B; Kumar, Uma; Tasset,...
Journal:
Rheumatology
Issue:
Volume 60(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results. (20th April 2020)

Authors:
Walker, David; Combe, Bernard G; Kivitiz, Alan J; Tanaka, Yoshiya; van der Heijde, Désirée; Matzkies, Franziska; Bartok, Beatrix; Ye, Lie; Guo, Ying; Tasset, Chantal; Sundy, John S; Mozaffarian, Neelufar; Landewé, Robert B. M; Bae, Sang-Cheol; Keystone, Edward C; Nash, Peter
Journal:
Rheumatology
Issue:
Volume 59(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P216 Effects of filgotinib on anaemia, thrombocytopoenia and leukopoenia: results from a Phase 3 study in patients with active RA and prior inadequate response or intolerance to bDMARDs. (20th April 2020)

Authors:
Walker, David; Genovese, Mark C; Kalunian, Kenneth; Gottenberg, Jacques-Eric; Bartok, Beatrix; Tan, YingMeei; Guo, Ying; Tasset, Chantal; Sundy, John S; de Vlam, Kurt; Takeuchi, Tsutomu
Journal:
Rheumatology
Issue:
Volume 59(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗